Nautilus Biotechnology, Inc. ·

NAUT 8-K 2026-09-11

Nautilus Biotechnology, Inc. (NAUT) 8-K dated 2026-09-11 — accession 0001808805-26-000041. This URL is the filing, not the NAUT hub.

Nautilus Biotechnology, Inc. (NAUT) is a biotechnology company listed on US.

Nautilus Biotechnology, Inc. filed a 8-K on 2026-09-11. Accession 0001808805-26-000041.

Cached items: 1.01, 1.02, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported NAUT revenue for 2026-06-30 was $190.0K. Net income was -$14.5M. NAUT currently screens at market cap $103.4M.

Not investment advice. The NAUT SEC hub lists recent forms. The stock page is the research view.

Source on EDGAR

These filings as JSON? API free 100/day

Lician Pro $19.99/mo or $149/yr